- Home
- HBB vs CATX Comparison
HBB vs CATX Comparison
Compare HBB & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HBB | CATX |
|---|---|---|
| Founded | 1904 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.9M | 211.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | HBB | CATX |
|---|---|---|
| Price | $16.75 | $2.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 30.8K | ★ 1.5M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | ★ 24.53 | N/A |
| EPS | ★ 2.34 | N/A |
| Revenue | ★ $607,430,000.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.06 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.72 | $1.60 |
| 52 Week High | $21.20 | $5.39 |
Technical Indicators
Market Signals| Indicator | HBB | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 53.90 |
| Support Level | $15.62 | $2.45 |
| Resistance Level | $17.23 | $2.88 |
| Average True Range (ATR) | 0.75 | 0.20 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 52.77 | 64.84 |
Price Performance
Historical ComparisonAbout HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.